.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Alprazolam - Generic Drug Details

« Back to Dashboard
Alprazolam is the generic ingredient in four branded drugs marketed by Sandoz, West-ward Pharms Int, Roxane, Mylan, Ani Pharms Inc, Ucb Inc, Pharmacia And Upjohn, Natco Pharma Ltd, Apotex Inc, Vintage Pharms, Actavis Elizabeth, Aurobindo Pharma Ltd, Mylan Pharms Inc, Watson Labs, Impax Labs, Anchen Pharms, Dava Intl Inc, Sandoz Inc, Sun Pharma Global, Amneal Pharms Ny, Par Pharm, Heritage Pharms Inc, Vintage, Ivax Sub Teva Pharms, Corepharma, and Actavis Labs Fl Inc, and is included in thirty-eight NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has thirteen patent family members in nine countries.

There are fifteen drug master file entries for alprazolam. Fifty-six suppliers are listed for this compound.

Summary for Generic Name: alprazolam

Tradenames:4
Patents:2
Applicants:26
NDAs:38
Drug Master File Entries: see list15
Suppliers / Packagers: see list56
Bulk Api Vendors: see list34
Clinical Trials: see list22
Patent Applications: see list25,625
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:alprazolam at DailyMed

Pharmacology for Ingredient: alprazolam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs
ALPRAZOLAM
alprazolam
TABLET, EXTENDED RELEASE;ORAL077968-004May 24, 2007DISCNNoNo► subscribe► subscribe
Sun Pharma Global
ALPRAZOLAM
alprazolam
TABLET;ORAL090082-001Jun 17, 2010RXNoNo► subscribe► subscribe
Ani Pharms Inc
ALPRAZOLAM
alprazolam
TABLET, EXTENDED RELEASE;ORAL077725-001Jul 31, 2006RXNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: alprazolam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
XANAX
alprazolam
TABLET;ORAL018276-003Approved Prior to Jan 1, 19823,980,789► subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-001Jan 17, 20035,061,494► subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-004Jan 17, 20035,061,494► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: alprazolam

Country Document Number Estimated Expiration
European Patent Office2266538► subscribe
Australia726336► subscribe
Canada2284663► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc